{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T05:35:21Z","timestamp":1738474521619,"version":"3.35.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.reumae.2025.101805","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T19:48:02Z","timestamp":1738352882000},"page":"101805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating potential biomarkers and therapeutic targets for patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) through the utilization of cytokine profiling"],"prefix":"10.1016","volume":"21","author":[{"given":"Akhil","family":"Akhil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsana","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.101805_bib0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.101805_bib0160","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.34483","article-title":"Large-scale analysis of tumor necrosis factor \u03b1 levels in systemic lupus erythematosus","volume":"64","author":"Weckerle","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.101805_bib0165","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.jtauto.2020.100042","article-title":"Urinary biomarkers in lupus nephritis","volume":"3","author":"Arag\u00f3n","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.reumae.2025.101805_bib0170","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.reumae.2025.101805_bib0175","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.reumae.2025.101805_bib0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.reumae.2025.101805_bib0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.reumae.2025.101805_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejr.2020.08.001","article-title":"Serum level of CXCL 12 in patients with systemic lupus erythematosus: is it worthy for predilection of lupus nephritis?","volume":"43","author":"Sallam","year":"2021","journal-title":"Egypt Rheumatol"},{"key":"10.1016\/j.reumae.2025.101805_bib0195","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10067-006-0387-y","article-title":"Association of serum MIP-1\u03b1, MIP-1\u03b2, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus","volume":"26","author":"Vil\u00e1","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.101805_bib0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.reumae.2025.101805_bib0205","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000382","article-title":"Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus","volume":"7","author":"Han","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.reumae.2025.101805_bib0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.reumae.2025.101805_bib0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nri2848","article-title":"Cellular sources and immune functions of interleukin-9","volume":"10","author":"Noelle","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.reumae.2025.101805_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.reumae.2025.101805_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6012715","article-title":"Chemokines and chemokine receptors in the development of lupus nephritis","volume":"2016","author":"Liao","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.reumae.2025.101805_bib0230","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.12659\/MSM.904364","article-title":"Cytokines interleukin 4 (IL-4) and interleukin 10 (IL-10) gene polymorphisms as potential host susceptibility factors in virus-induced encephalitis","volume":"23","author":"Yu","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.reumae.2025.101805_bib0235","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2004-10-4055","article-title":"Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production","volume":"106","author":"Bracci-Laudiero","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.reumae.2025.101805_bib0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbf.3260","article-title":"Osteoclast differentiation gene expression profiling reveals chemokine CCL4 mediates RANKL-induced osteoclast migration and invasion via PI3K pathway","volume":"35","author":"Xuan","year":"2017","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.reumae.2025.101805_bib0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0145-2126(00)00097-7","article-title":"The levels of TNF\u03b1, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL)","volume":"25","author":"Mainou-Fowler","year":"2001","journal-title":"Leukemia Res"},{"key":"10.1016\/j.reumae.2025.101805_bib0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","article-title":"The multifactorial role of neutrophils in rheumatoid arthritis","volume":"10","author":"Wright","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reumae.2025.101805_bib0255","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/eji.201646542","article-title":"Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation","volume":"46","author":"Papadaki","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.reumae.2025.101805_bib0260","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bcp.13748","article-title":"Anti-IL-7 receptor \u03b1 monoclonal antibody (GSK2618960) in healthy subjects \u2013 a randomized, double-blind, placebo-controlled study","volume":"85","author":"Ellis","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.reumae.2025.101805_bib0265","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/art.10814","article-title":"Association of interleukin-18 expression with enhanced levels of both interleukin-1\u03b2 and tumor necrosis factor \u03b1 in knee synovial tissue of patients with rheumatoid arthritis","volume":"48","author":"Joosten","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.101805_bib0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1100869","article-title":"Chemokines and chemokine receptors as promising targets in rheumatoid arthritis","volume":"14","author":"Murayama","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.reumae.2025.101805_bib0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/0891693031000079275","article-title":"Effect of pro-inflammatory\/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus","volume":"36","author":"Scuderi","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.reumae.2025.101805_bib0280","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1038\/s41598-021-87199-7","article-title":"Eotaxin-1\/CCL11 is involved in cell migration in rheumatoid arthritis","volume":"11","author":"Wakabayashi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2025.101805_bib0285","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203318812679","article-title":"Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus","volume":"28","author":"Pacheco-Lugo","year":"2019","journal-title":"Lupus."},{"key":"10.1016\/j.reumae.2025.101805_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2022.5098","article-title":"Tumor necrosis factor-\u03b1 in systemic lupus erythematosus: structure, function and therapeutic implications","volume":"49","author":"Ghorbaninezhad","year":"2022","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.reumae.2025.101805_bib0295","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.imbio.2011.04.001","article-title":"Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis","volume":"216","author":"Shah","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.reumae.2025.101805_bib0300","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.2147\/DDDT.S281854","article-title":"Edaravone and acetovanillone upregulate Nrf2 and PI3K\/Akt\/mTOR signaling and prevent cyclophosphamide cardiotoxicity in rats","volume":"2020","author":"Hassanein","year":"2020","journal-title":"Drug Des Devel Ther"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T03:17:07Z","timestamp":1738466227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2173574325000140"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.101805","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating potential biomarkers and therapeutic targets for patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) through the utilization of cytokine profiling","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.101805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101805"}}